Importation and Innovation

Frank R. Lichtenberg

NBER Working Paper No. 12539
Issued in September 2006
NBER Program(s):   EFG   HC   ITI   PR

Importation of drugs into the U.S. would result in a decline in U.S. drug prices. The purpose of this paper is to assess the consequences of importation for new drug development. A simple theoretical model of drug development suggests that the elasticity of innovation with respect to the expected price of drugs should be at least as great as the elasticity of innovation with respect to expected market size (disease incidence). I examine the cross-sectional relationship between pharmaceutical innovation and market size among a set of diseases (different types of cancer) exhibiting substantial exogenous variation in expected market size. I analyze two different measures of pharmaceutical innovation: the number of distinct chemotherapy regimens for treating a cancer site, and the number of articles published in scientific journals pertaining to drug therapy for that cancer site. Both analyses indicate that the amount of pharmaceutical innovation increases with disease incidence. The elasticity of the number of chemotherapy regimens with respect to the number of cases is 0.53. The elasticity of MEDLINE drug cites with respect to cancer incidence throughout the world is 0.60. In the long run, a 10% decline in drug prices would therefore be likely to cause at least a 5-6% decline in pharmaceutical innovation.

download in pdf format
   (258 K)

email paper

The NBER Bulletin on Aging and Health provides summaries of publications like this.  You can sign up to receive the NBER Bulletin on Aging and Health by email.

This paper is available as PDF (258 K) or via email.

Machine-readable bibliographic record - MARC, RIS, BibTeX

Document Object Identifier (DOI): 10.3386/w12539

Published: Frank R. Lichtenberg, 2007. "Importation And Innovation," Economics of Innovation and New Technology, Taylor and Francis Journals, vol. 16(6), pages 403-417. citation courtesy of

Users who downloaded this paper also downloaded these:
Lichtenberg w6569 Pharmaceutical Innovation, Mortality Reduction, and Economic Growth
Abbott and Vernon w11114 The Cost of US Pharmaceutical Price Reductions: A Financial Simulation Model of R&D Decisions
Bloom, Draca, and Van Reenen w16717 Trade Induced Technical Change? The Impact of Chinese Imports on Innovation, IT and Productivity
Lichtenberg w18235 Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009
Kyle w12968 Strategic Responses to Parallel Trade
NBER Videos

National Bureau of Economic Research, 1050 Massachusetts Ave., Cambridge, MA 02138; 617-868-3900; email:

Contact Us